JP2010508336A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010508336A5 JP2010508336A5 JP2009535115A JP2009535115A JP2010508336A5 JP 2010508336 A5 JP2010508336 A5 JP 2010508336A5 JP 2009535115 A JP2009535115 A JP 2009535115A JP 2009535115 A JP2009535115 A JP 2009535115A JP 2010508336 A5 JP2010508336 A5 JP 2010508336A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- carbamoyl
- hydrogen
- cyclopentyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims description 19
- 239000001257 hydrogen Substances 0.000 claims description 19
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 18
- -1 chloro, methyl Chemical group 0.000 claims description 13
- 125000006413 ring segment Chemical group 0.000 claims description 8
- 125000004185 ester group Chemical group 0.000 claims description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 125000000623 heterocyclic group Chemical group 0.000 claims description 4
- 125000002950 monocyclic group Chemical group 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 2
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims description 2
- 125000001989 1,3-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([H])C([*:2])=C1[H] 0.000 claims description 2
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 claims description 2
- 108090000371 Esterases Proteins 0.000 claims description 2
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 claims description 2
- 235000008206 alpha-amino acids Nutrition 0.000 claims description 2
- 125000002527 bicyclic carbocyclic group Chemical group 0.000 claims description 2
- 125000002619 bicyclic group Chemical group 0.000 claims description 2
- 125000002843 carboxylic acid group Chemical group 0.000 claims description 2
- 125000004122 cyclic group Chemical group 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims description 2
- 125000001072 heteroaryl group Chemical group 0.000 claims description 2
- 230000003834 intracellular effect Effects 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 150000003568 thioethers Chemical class 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims 13
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 12
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 claims 9
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- IPBVNPXQWQGGJP-UHFFFAOYSA-N phenyl acetate Chemical compound CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 claims 3
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 2
- 150000001204 N-oxides Chemical class 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 101150065749 Churc1 gene Proteins 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 206010015150 Erythema Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 102100038239 Protein Churchill Human genes 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- DGYIJVNZSDYBOE-UHFFFAOYSA-N [CH2]C1=CC=NC=C1 Chemical group [CH2]C1=CC=NC=C1 DGYIJVNZSDYBOE-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 230000010261 cell growth Effects 0.000 claims 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 231100000321 erythema Toxicity 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 208000026278 immune system disease Diseases 0.000 claims 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 206010025135 lupus erythematosus Diseases 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000001620 monocyclic carbocycle group Chemical group 0.000 claims 1
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 1
- 125000006203 morpholinoethyl group Chemical group [H]C([H])(*)C([H])([H])N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 125000005550 pyrazinylene group Chemical group 0.000 description 1
- 125000005551 pyridylene group Chemical group 0.000 description 1
- 125000005576 pyrimidinylene group Chemical group 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0621720A GB0621720D0 (en) | 2006-11-01 | 2006-11-01 | Inhibitors of ikk- serine-threonine protein kinase |
| GB0715470A GB0715470D0 (en) | 2007-08-09 | 2007-08-09 | IKK- serine-threonine protein kinase inhibitors |
| PCT/GB2007/004114 WO2008053182A1 (en) | 2006-11-01 | 2007-10-29 | IKK-β SERINE-THREONINE PROTEIN KINASE INHIBITORS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010508336A JP2010508336A (ja) | 2010-03-18 |
| JP2010508336A5 true JP2010508336A5 (cg-RX-API-DMAC7.html) | 2010-12-16 |
Family
ID=39015937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009535115A Withdrawn JP2010508336A (ja) | 2006-11-01 | 2007-10-29 | ＩＫＫ−βセリン−スレオニンプロテインキナーゼ阻害剤 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8003695B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2078007B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2010508336A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20090077975A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE522516T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007315943A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0718056A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2668338A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2078007T3 (cg-RX-API-DMAC7.html) |
| EA (1) | EA200900616A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2372707T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL198267A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2009004442A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ576705A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008053182A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0619753D0 (en) | 2006-10-06 | 2006-11-15 | Chroma Therapeutics Ltd | Enzyme inhibitors |
| GB0803747D0 (en) | 2008-02-29 | 2008-04-09 | Martin | Enzyme and receptor modulation |
| WO2009130434A1 (en) * | 2008-04-23 | 2009-10-29 | Chroma Therapeutics Ltd. | INHIBITORS OF IKK-β SERINE-THREONINE PROTEIN KINASE |
| CA2722660A1 (en) * | 2008-04-26 | 2009-10-29 | Chroma Therapeutics Ltd. | Substituted thiophenecarboxamides as ikk-beta serine-, threonine-protein kinase inhibitors |
| WO2010060214A1 (en) * | 2008-11-26 | 2010-06-03 | Trt Pharma Inc . | Hybrid -ionone and curcumin molecules as anticancer agents |
| GB0903480D0 (en) | 2009-02-27 | 2009-04-08 | Chroma Therapeutics Ltd | Enzyme Inhibitors |
| GB0907120D0 (en) * | 2009-04-24 | 2009-06-03 | Chroma Therapeutics Ltd | Inhibitors of IKK-ß serine-threonine protein kinase |
| GB201211310D0 (en) | 2012-06-26 | 2012-08-08 | Chroma Therapeutics Ltd | CSF-1R kinase inhibitors |
| BR112015008167B1 (pt) | 2012-10-17 | 2020-11-17 | Macrophage Pharma Limited | composto, composição farmacêutica, métodos para a inibição da atividade de uma enzima quinase map p38, para o tratamento ou a prevenção de doença autoimune ou inflamatória em um indivíduo, e para o tratamento, a melhoria ou a redução da incidência de doença proliferativa de células em um indivíduo, uso de composto, e, ácido |
| HRP20181109T1 (hr) * | 2013-12-11 | 2018-11-02 | Biogen Ma Inc. | Spojevi biarila korisni za liječenje ljudskih bolesti u onkologiji, neurologiji i imunologiji |
| GB201713975D0 (en) | 2017-08-31 | 2017-10-18 | Macrophage Pharma Ltd | Medical use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0102616D0 (sv) | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
| SE0300092D0 (sv) | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
-
2007
- 2007-10-29 ES ES07824358T patent/ES2372707T3/es active Active
- 2007-10-29 BR BRPI0718056-0A patent/BRPI0718056A2/pt not_active IP Right Cessation
- 2007-10-29 MX MX2009004442A patent/MX2009004442A/es active IP Right Grant
- 2007-10-29 EP EP07824358A patent/EP2078007B1/en not_active Not-in-force
- 2007-10-29 DK DK07824358.1T patent/DK2078007T3/da active
- 2007-10-29 KR KR1020097011261A patent/KR20090077975A/ko not_active Withdrawn
- 2007-10-29 NZ NZ576705A patent/NZ576705A/en not_active IP Right Cessation
- 2007-10-29 CA CA002668338A patent/CA2668338A1/en not_active Abandoned
- 2007-10-29 JP JP2009535115A patent/JP2010508336A/ja not_active Withdrawn
- 2007-10-29 US US12/513,206 patent/US8003695B2/en not_active Expired - Fee Related
- 2007-10-29 WO PCT/GB2007/004114 patent/WO2008053182A1/en not_active Ceased
- 2007-10-29 AT AT07824358T patent/ATE522516T1/de not_active IP Right Cessation
- 2007-10-29 EA EA200900616A patent/EA200900616A1/ru unknown
- 2007-10-29 AU AU2007315943A patent/AU2007315943A1/en not_active Abandoned
-
2009
- 2009-04-21 IL IL198267A patent/IL198267A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010508336A5 (cg-RX-API-DMAC7.html) | ||
| JP2010508337A5 (cg-RX-API-DMAC7.html) | ||
| JP2010505802A5 (cg-RX-API-DMAC7.html) | ||
| ES2711727T3 (es) | Derivados de N'-[2.metil-6-[2-alcoxi-etoxi]-3-piridil]-N-alquil-formamidina fungicidas para uso en agricultura | |
| JP2009535385A5 (cg-RX-API-DMAC7.html) | ||
| US6846819B1 (en) | Fab I inhibitors | |
| US8999989B2 (en) | Benzene or thiophene derivative and use thereof as VAP-1 inhibitor | |
| JP2008540389A5 (cg-RX-API-DMAC7.html) | ||
| US8076486B2 (en) | Heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors | |
| US8912182B2 (en) | Viral polymerase inhibitors | |
| JPH06507394A (ja) | 殺菌剤として置換−２−フェニル−３−メトキシプロペノエート | |
| US20110112110A1 (en) | Antiproliferative compounds and therapeutic uses thereof | |
| JP2009535387A5 (cg-RX-API-DMAC7.html) | ||
| CA2683696A1 (en) | Dpp-iv inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating a diabetes or an obesity | |
| WO2007126043A1 (ja) | チアゾール環を含むカルボン酸誘導体の医薬用途 | |
| HU207720B (en) | Process for producing thiazolyl-alkoxy-acrilates and fungicide compositions containing them | |
| JP2012519162A5 (cg-RX-API-DMAC7.html) | ||
| EP0296673B1 (en) | Thiazole derivatives | |
| CN1032183C (zh) | 含有丙烯酸衍生物的农用杀菌剂及其制法 | |
| JP2007500222A5 (cg-RX-API-DMAC7.html) | ||
| JP2014513703A5 (cg-RX-API-DMAC7.html) | ||
| JP2004520423A5 (cg-RX-API-DMAC7.html) | ||
| JP4939226B2 (ja) | チアゾール環を含むカルボン酸誘導体およびその医薬用途 | |
| JP2011503042A (ja) | ｐ３８ＭＡＰキナーゼ阻害剤 | |
| CN101910149A (zh) | 哒嗪杀真菌剂 |